Sens A, Rischke S, Hahnefeld L, Dorochow E, Schafer SMG, Thomas D, Kohm M, Geisslinger G, Behrens F, Gurke R
Notable are the EMPA-REG OUTCOME trial, which showed a significant reduction in aminotransferases with empagliflozin 47 , and a meta-analysis of ten randomized controlled trials with 573 participants that confirmed the superiority of SGLT2 inhibitors over other antihyperglycemic agents in terms of improvement in hepatic and metabolic parameters 48
Related Reading Ozempic Side Effects Mounjaro Side Effects Plexusdx Glp 1 Side Effects Plexusdx Tirzepatide Vs Semaglutide Side Effects Pricing and availability current as of June 2026
When to seek medical attention Seek immediate medical care for: Any signs of severe allergic reaction Fever with injection site infection signs Chest pain or significant cardiovascular symptoms Severe or persistent neurological symptoms Any symptom that feels like a medical emergency Seek prompt (but not emergency) medical attention for: Symptoms that persist beyond two weeks without improvement Symptoms that progressively worsen rather than improve New symptoms that appear after initial adjustment period Any symptom that significantly impairs daily function Do not let concern about discussing peptide use prevent you from seeking appropriate care
GLP-1 impact on psychostimulant and nicotine reward Considering that the mesolimbic reward system is a key target not only for food and alcohol, but also for psychostimulants and nicotine (Koob, 1992), it is perhaps not surprising that recent work has explored the potential of GLP-1 analogs to alter psychostimulant reward